BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10320524)

  • 21. Sox9 is required for cartilage formation.
    Bi W; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B
    Nat Genet; 1999 May; 22(1):85-9. PubMed ID: 10319868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro.
    Hargus G; Kist R; Kramer J; Gerstel D; Neitz A; Scherer G; Rohwedel J
    Int J Dev Biol; 2008; 52(4):323-32. PubMed ID: 18415932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis.
    Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E
    Development; 2007 Nov; 134(21):3917-28. PubMed ID: 17913788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence on spatiotemporal patterns of a male-specific Sox9 activation by ectopic Sry expression during early phases of testis differentiation in mice.
    Kidokoro T; Matoba S; Hiramatsu R; Fujisawa M; Kanai-Azuma M; Taya C; Kurohmaru M; Kawakami H; Hayashi Y; Kanai Y; Yonekawa H
    Dev Biol; 2005 Feb; 278(2):511-25. PubMed ID: 15680367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
    Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
    J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The porcine SRY promoter is transactivated within a male genital ridge environment.
    Daneau I; Pilon N; Boyer A; Behdjani R; Overbeek PA; Viger R; Lussier J; Silversides DW
    Genesis; 2002 Aug; 33(4):170-80. PubMed ID: 12203914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the mouse cartilage-derived retinoic acid-sensitive protein gene by the transcription factor AP-2.
    Xie WF; Kondo S; Sandell LJ
    J Biol Chem; 1998 Feb; 273(9):5026-32. PubMed ID: 9478951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9.
    Cucchiarini M; Thurn T; Weimer A; Kohn D; Terwilliger EF; Madry H
    Arthritis Rheum; 2007 Jan; 56(1):158-67. PubMed ID: 17195218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
    Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
    Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype.
    Yagi R; McBurney D; Laverty D; Weiner S; Horton WE
    J Orthop Res; 2005 Sep; 23(5):1128-38. PubMed ID: 15936918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis.
    Appleton CT; Usmani SE; Bernier SM; Aigner T; Beier F
    Arthritis Rheum; 2007 Nov; 56(11):3693-705. PubMed ID: 17968906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transcription factor Znf219 regulates chondrocyte differentiation by assembling a transcription factory with Sox9.
    Takigawa Y; Hata K; Muramatsu S; Amano K; Ono K; Wakabayashi M; Matsuda A; Takada K; Nishimura R; Yoneda T
    J Cell Sci; 2010 Nov; 123(Pt 21):3780-8. PubMed ID: 20940257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible roles of Runx1 and Sox9 in incipient intramembranous ossification.
    Yamashiro T; Wang XP; Li Z; Oya S; Aberg T; Fukunaga T; Kamioka H; Speck NA; Takano-Yamamoto T; Thesleff I
    J Bone Miner Res; 2004 Oct; 19(10):1671-7. PubMed ID: 15355562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sox9-dependent transcriptional regulation of the proprotein convertase furin.
    Guimont P; Grondin F; Dubois CM
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C172-83. PubMed ID: 17360815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional Co-activators CREB-binding protein/p300 increase chondrocyte Cd-rap gene expression by multiple mechanisms including sequestration of the repressor CCAAT/enhancer-binding protein.
    Imamura T; Imamura C; Iwamoto Y; Sandell LJ
    J Biol Chem; 2005 Apr; 280(17):16625-34. PubMed ID: 15722556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination.
    Gasca S; Canizares J; De Santa Barbara P; Mejean C; Poulat F; Berta P; Boizet-Bonhoure B
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11199-204. PubMed ID: 12169669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells.
    Fernández-Lloris R; Viñals F; López-Rovira T; Harley V; Bartrons R; Rosa JL; Ventura F
    Mol Endocrinol; 2003 Jul; 17(7):1332-43. PubMed ID: 12677004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Sox9 activity by crosstalk with nuclear factor-kappaB and retinoic acid receptors.
    Rockel JS; Kudirka JC; Guzi AJ; Bernier SM
    Arthritis Res Ther; 2008; 10(1):R3. PubMed ID: 18182117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors.
    Stokes DG; Liu G; Dharmavaram R; Hawkins D; Piera-Velazquez S; Jimenez SA
    Biochem J; 2001 Dec; 360(Pt 2):461-70. PubMed ID: 11716775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia.
    Sock E; Pagon RA; Keymolen K; Lissens W; Wegner M; Scherer G
    Hum Mol Genet; 2003 Jun; 12(12):1439-47. PubMed ID: 12783851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.